KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Intangibles (2020 - 2024)

Aurinia Pharmaceuticals (AUPH) has disclosed Change in Intangibles for 4 consecutive years, with $129000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Change in Intangibles rose 360.71% year-over-year to $129000.0, compared with a TTM value of $253000.0 through Sep 2024, up 5.42%, and an annual FY2019 reading of $16000.0, changed N/A over the prior year.
  • Change in Intangibles was $129000.0 for Q3 2024 at Aurinia Pharmaceuticals, up from $84000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $162000.0 in Q1 2023 and bottomed at -$83000.0 in Q4 2021.
  • Average Change in Intangibles over 4 years is $46636.4, with a median of $48000.0 recorded in 2020.
  • Peak annual rise in Change in Intangibles hit 360.71% in 2024, while the deepest fall reached 92.59% in 2024.
  • Year by year, Change in Intangibles stood at $4000.0 in 2020, then crashed by 2175.0% to -$83000.0 in 2021, then surged by 133.73% to $28000.0 in 2023, then skyrocketed by 360.71% to $129000.0 in 2024.
  • Business Quant data shows Change in Intangibles for AUPH at $129000.0 in Q3 2024, $84000.0 in Q2 2024, and $12000.0 in Q1 2024.